Skip to content

A clinical trial to study the effect of Lekhaniya Mahakashaya Yoga Basti And Apamarga Kshara Taila Uttara Basti along with Rasanadi Ksheerpaka in the management of adenomyosis

Effect of lekhaniya mahakashaya yoga basti and apamarga Kshara taila uttara basti along with rasanadi Ksheerpaka in the management of adenomyosis

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052788
Enrollment
30
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N711- Chronic inflammatory disease of uterus

Interventions

None listed

Sponsors

National Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to give voluntary informed consent. 2.Married women of age group between 21-45 yrs. 3.Patients having any two complaints either menorrhagia, dysmenorrhea,dyspareunia, or infertility and diagnosis of adenomyosis confirmed by TVS or any other diagnostic techniques. 4.Patients who are yogya for basti and Uttara basti.

Exclusion criteria

Exclusion criteria: 1.Pregnant woman. 2.Patient having any systemic diseases like Diabetes (FBS >126mg/dl), Hypertension ( >140/100 mmHg), severe anaemia (Hb 3.Congenital anomaly of reproductive tract. 4.Patient having any type of malignancy. 5. Acute inflammatory disease like Acute PID & Sexually Transmitted Diseases like HIV, VDRL,HBsAg,HCV positive females. 6.Patient using oral contraceptive pills and Intra Uterine Contraceptive Devices. 7.Patient with thyroid hormone abnormalities. 8.Patients Ayogya (contraindicated) and not willing for Basti and Uttara basti.

Design outcomes

Primary

MeasureTime frame
1. Changes in the clinical features (interval between two menstrual cycle , duration of menstrual bleeding ,quantity of menstrual bleeding , pain during menses , dyspareunia and infertility ) and assess adenomyotic changes in uterus (adenomyotic foci either focal or diffuse, Location, cystic changes, uterine layer involvement ,uterine volume ,endometrial thickness of uterus).Timepoint: 90 DAYS

Secondary

MeasureTime frame
1. Changes in quality of life (WHOQOL-BREF SCALE).Timepoint: 90 DAYS

Countries

India

Contacts

Public ContactDr Poonam Choudhary

National Institute of ayurveda

poonam.18veena@gmail.com9352311106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026